EFFECT OF 7-NITRO INDAZOLE ON NEUROTRANSMISSION IN THE RAT VAS-DEFERENS - MECHANISMS UNRELATED TO INHIBITION OF NITRIC-OXIDE SYNTHASE

被引:18
作者
ALLAWI, HS [1 ]
WALLACE, P [1 ]
PITCHER, A [1 ]
GAFFEN, Z [1 ]
BLANDWARD, PA [1 ]
MOORE, PK [1 ]
机构
[1] UNIV LONDON,UNIV LONDON KINGS COLL,DIV BIOMED SCI,PHARMACEUT GRP,LONDON SW3 6LX,ENGLAND
关键词
7-NITRO INDAZOLE; L-NAME; L-ARGININE; VAS DEFERENS; P-2X PURINOCEPTORS; ALPHA; BETA-METHYLENE ATP; ADRENOCEPTORS; CALCIUM INFLUX;
D O I
10.1111/j.1476-5381.1994.tb16206.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effect of the nitric oxide synthase (NOS) inhibitor, 7-nitro indazole (7-NI), on sympathetic and purinergic neurotransmission in the rat isolated vas deferens preparation has been studied. 2 7-NI (50-200 mu M) caused a dose- and frequency-dependent inhibition of the phasic (predominantly purinergic) contractile response of the rat vas deferens to electrical (field) stimulation (100 V, 0.5 ms). Greatest inhibition occurred at lower frequencies of stimulation (0.1-10 Hz). The sustained tonic contractile response (predominantly noradrenergic) was inhibited only at a high frequency of stimulation (60 Hz) and only at the highest concentration of 7-NI studied (200 mu M). 3 7-NI (100 mu M) significantly reduced the contractile response of the vas deferens to exogenous ATP (20 mu M-5 mM) and the stable P-2X purinoceptor agonist, alpha,beta-methylene ATP (2.5 and 25.0 mu M) but was without effect on contractions due to noradrenaline (0.1-50 mu M) indicating a lack of antagonist effect on post-junctional alpha(1) adrenoceptors. 4 The effect of 7-NI (100 mu M) on the phasic contractile response to field stimulation (0.1 and 2.0 Hz) was unaffected by preincubation of preparations with yohimbine (1.0 mu M) or propranolol (0.01-10.0 mu M) indicating the absence of involvement of alpha(2)- or beta-adrenoceptors in this response. 5 7-NI (50-600 mu M) caused dose-related inhibition of contractions elicited by addition of a depolarizing concentration of KCl (64 mM). 6 The effect of 7-NI (100 mu M) on the phasic contractile response to held stimulation (0.1 and 2.0 Hz) was unaffected by preincubation of preparations with L-arginine (1 mM). Neither L-arginine (1 mM) nor N-G nitro L-arginine methyl ester (L-NAME, 100 mu M) affected the response of the vas deferens to field stimulation at 0.1 or 2.0 Hz. Nitric oxide synthase (NOS) enzyme activity, measured as the conversion of [H-3]-L-arginine to [H-3]-citrulline, was not detectable in rat vas deferens homogenates. 7 7-NI preferentially inhibits the purinergic component of the response of the rat vas deferens to held stimulation. The mechanism of action of 7-NI is not known but is not related to NOS inhibition. It seems likely that 7-NI combines an antagonist action at smooth muscle cell P-2X-purinoceptors with the ability to inhibit the cellular influx of calcium ions. Although these hitherto unrecorded effects of 7-NI occur at relatively high concentrations, the effects described may contribute to the pharmacological effects of this NOS inhibitor.
引用
收藏
页码:282 / 288
页数:7
相关论文
共 27 条
[1]   ADRENERGIC AND NONADRENERGIC CONTRIBUTIONS TO THE 2-COMPONENT TETANUS IN THE RAT VAS-DEFERENS [J].
AMOBI, NIB ;
SMITH, ICH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 135 (02) :173-182
[2]   INHIBITION OF RAT CEREBELLAR NITRIC-OXIDE SYNTHASE BY 7-NITRO INDAZOLE AND RELATED SUBSTITUTED INDAZOLES [J].
BABBEDGE, RC ;
BLANDWARD, PA ;
HART, SL ;
MOORE, PK .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (01) :225-228
[3]  
BABBEDGE RC, 1993, BRIT J PHARMACOL, V109, pP142
[4]   MECHANISMS OF ACTION OF TRANSMITTERS AND OTHER SUBSTANCES ON SMOOTH-MUSCLE [J].
BOLTON, TB .
PHYSIOLOGICAL REVIEWS, 1979, 59 (03) :606-718
[5]   EFFECTS OF ALPHA-ADRENOCEPTOR AGONISTS AND ANTAGONISTS ON RESPONSES OF TRANSMURALLY STIMULATED PROSTATIC AND EPIDIDYMAL PORTIONS OF THE ISOLATED VAS-DEFERENS OF THE RAT [J].
BROWN, CM ;
MCGRATH, JC ;
SUMMERS, RJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1979, 66 (04) :553-564
[6]   PRESYNAPTIC ALPHA-2-AUTOINHIBITION IN A VASCULAR NEUROEFFECTOR JUNCTION WHERE ATP AND NORADRENALINE ACT AS CO-TRANSMITTERS [J].
BULLOCH, JM ;
STARKE, K .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (02) :279-284
[7]   IS THERE A BASIS FOR DISTINGUISHING 2 TYPES OF P2-PURINOCEPTOR [J].
BURNSTOCK, G ;
KENNEDY, C .
GENERAL PHARMACOLOGY, 1985, 16 (05) :433-440
[8]   SURAMIN - A REVERSIBLE P2-PURINOCEPTOR ANTAGONIST IN THE MOUSE VASDEFERENS [J].
DUNN, PM ;
BLAKELEY, AGH .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (02) :243-245
[9]  
FEDAN JS, 1981, EUR J PHARMACOL, V81, P193
[10]  
GANGULY DK, 1969, ARCH INT PHARMACOD T, V185, P406